UnknownPHASE1, PHASE2NCT01790893
Treatment for Presumed Ocular Histoplasmosis
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- John Kitchens, MD
- Principal Investigator
- John W Kitchens, MDRetina Associates of Kentucky
- Intervention
- aflibercept(drug)
- Enrollment
- 40 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2014
Study locations (3)
- Southeast Retina, Augusta, Georgia, United States
- Retina Associates of Kentucky, Lexington, Kentucky, United States
- Cincinnati Eye Institute, Cincinnati, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01790893 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.